Patrice Boyer is Chair of the EBF, the immediate past vice-president of the European Brain Council (EBC) and a past President of the European Psychiatric Association (EPA). He is Honorary Professor of Neurosciences and Psychiatry at the University Paris-Diderot (France) and Professor of Psychiatry and post graduate studies (geographical) at the University of Ottawa, Ontario, Canada. He is the founding editor of the journal European Psychiatry, the co-founder of the French Congress of Psychiatry, and a member of the International Scientific Advisory Board of the main foundation for research in neurosciences and psychiatry in France (Fondamental). Trained in neurology and psychiatry, Prof Boyer used to be previously the co-Chairman of the Master and Doctorate courses for Neurobiology at the Universities of Paris 5 and Paris 7 and the advisor for psychiatry in the then newly created INSERM thematic institute (ITMO Neurosciences).
Audrey Craven is the Vice Chair of the EBF, the founder and president of the Migraine Association of Ireland (MAI) and an internationally acknowledged patient advocate for migraine. Audrey, a lifelong migraineur, is committed to sharing hard-won experience of migraine self-management in the hope of improving quality of life for all those affected. She is the past president of both the European Migraine and Headache Alliance (EMHA) and the European Federation of Neurological Associations (EFNA). Audrey was the only patient representative on the European Commission’s ‘Healthy Brain; Healthy Europe’ scientific board for European Month of the Brain 2013.
Christina Dalla is Board Member of the EBF, Associate Professor of Pharmacology, Neuropsychopharmacology group, Medical School, National & Kapodistrian University of Athens, and President-elect of the Mediterranean Neuroscience Society and founding member of the Hellenic Brain Council. Dr Dalla’s research focuses on the neurobiological mechanisms mediating male and female vulnerability to stress-related mental illnesses, such as depression, as well as sex differences in treatment response. Dr Dalla currently investigates the role of neurosteroids and neural circuits in sex differences in depression with the use of pharmacological, behavioral and neurochemical methods. Dr Dalla has earned two Marie Curie fellowships, a L’Oreal-Unesco award for young women in science and a European College of Neuropsychopharmacology fellowship award.
Philip Gorwood is Board Member at the EBF, a psychiatrist specialised in addictive and eating disorders. He is leading a 60-bed department at Sainte-Anne hospital in Paris (GHU Paris Psychiatrie et Neurosciences), teaching at Université Paris Cité, and head of a research team devoted to behavioural genetics at the IPNP (Institute of Psychiatry and Neurosciences, INSERM U1266). Prof. Gorwood has published over 300 scientific articles (h-index=50) and has been quoted as the presently “most frequently quoted French psychiatrist” (Ioannidis et al., 2019). He has served on 16 editorial boards for journals in psychiatry, neuroscience, and genetics, and was editor-in-chief of the journal European Psychiatry (IF=5.3), from 2005 to 2017. He is past president (2020-2022) of the European Psychiatric Association (EPA).
Lieven Lagae is Board Member at the EBF, Full Professor and Head of Paediatric Neurology Department at the University Hospitals of Leuven, Belgium. He has a particular clinical and scientific interest in childhood epilepsy and is involved in many research projects including zebrafish epilepsy models, brain stimulation, preventive treatment in TSC, the use of fenfluramine and analogues in Dravet and Lennox Gastaut syndromes. Lieven Lagae is the immediate past President of the European Paediatric Neurology Society (EPNS). He is the current Chair of Medical Treatment Commission of the International League Against Epilepsy. He received the ‘Cures within Reach Patient Impact Clinical Award’ in 2017, the 2019 Honorary Award of German speaking Pediatric Neurology Society and the 2019 Aicardi Award of the EPNS.
Laurence Lanfumey-Mongredien is Board Member of the EBF, Emeritus Research Director at Inserm, at the Institute of Psychiatry and Neurosciences of Paris (IPNP), France. She has dedicated her professional activity to the regulation of phenotypes associated with psychiatric pathologies, mainly post-traumatic stress, anxiety-depressive disorders, and addiction. In this context, she has characterized serotonergic neurotransmission in relation to the corticotropic and neurotrophic systems, as well as the role of epigenetic mechanisms through a multidisciplinary approach, from molecular biology to behavioral studies. She has served in several scientific organizations and was vice-president of the European College of Neuropsychopharmacology (ECNP). She coordinates Brain Awareness Week in France.
Micaela Morelli is Board Member at the EBF, a past elected President of the Italian Neuroscience Society and Vice Rector for Research at University of Cagliari. She is part of the higher education committee (CHET) of the FENS Society. The principal subjects of investigation are on the mechanism of action of drugs affecting dopaminergic and adenosinergic transmission and their potential combined utilization in the therapy of Parkinson’s disease. In addition, Prof. Morelli studies the mechanisms of toxicity induced by amphetamine-like substance of abuse (ecstasy) and their neurodegenerative and neuroinflammatory properties.
Dr Matt Muijen is Board Member at the EBF, an international mental health policy adviser, formerly the Regional Adviser for Mental Health and Intellectual Disabilities at the WHO Regional Office for Europe where he was responsible for planning and coordinating mental health policies and activities in the Region. He is active as a consultant to WHO and is also a Board Member and chair of the research committee of GAMIAN-Europe and trustee of Sporting Chance in the UK. Until April 2004 he was Chief Executive of the Sainsbury Centre for Mental Health in London for 12 years, a policy and research institute closely involved with mental health care reforms in the UK. His background is a community psychiatrist and epidemiologist, and he trained in Cambridge and the Institute of Psychiatry in London.
Christian Suojanen is Board Member of the EBF, the Founder & CEO of Broadreach Global, a boutique strategy, business and innovation advisor in the biotech, health, and pharma sectors. With 24 years strategic advisory, innovation, business and operational experience, he advises start-up, growth companies, investors, governments, university networks, and health systems. Prior to Broadreach, he founded and chaired the leading international biotech and health focused platform for connecting technology transfer, licensing and innovation office directors with serial entrepreneurs, industry, and investors, led a successful turn-around of Europe’s oldest biotech federation, and coordinated the first EU level biotech CEO bootcamp and investment forum.
Dr. Manfred Westphal is Board Member at the EBF and was the Director of the Department of Neurosurgery for the University Clinic Hamburg-Eppendorf (UCHE) in Hamburg, Germany until September 2022. Dr. Westphal is specialized in neuro-oncology and neurovascular diseases. He has published almost 400 PubMed-listed publications, 50 book chapters and edited/co-edited six books. He is now senior professor of neurosurgery at the UCHE.
In addition to his appointment at UCHE, Dr. Westphal is also a member of the German Society of Neurosurgery, the American Society for Neurosurgery, the European Association of Neurosurgical Societies and is a Past President of the German Academy of Neurosurgery.
In addition to his appointment at UCHE, Dr. Westphal is also a member of the German Society of Neurosurgery, the American Society for Neurosurgery, the European Association of Neurosurgical Societies and is a Past President of the German Academy of Neurosurgery.
